Associations between HDAC1 or HDAC2 expression with neoadjuvant chemotherapy were evaluated by comparing HDAC1 or HDAC2 expression in pre-therapeutic tumour biopsies against histopathological tumour regression after treatment. The gene discussed is HDAC1; the disease is neoplasm.